Appeal No. 2006-2415 Page 6 Application No. 09/410,336 Willich, column 8, lines 19-27 and 44-52. One of ordinary skill using Yoshimoto’s ductal injection methods for locating breast tumors would also have considered it obvious to attach Schmitt-Willich’s gadolinium-polymer complex to an antibody specific for breast tumors, since Schmitt-Willich teaches that gadolinium-polymer complexes attached to monoclonal antibodies specific for human breast tumors can be used “for visualization of tumors.” Id. at column 13, lines 25-52. We also agree that a person of ordinary skill, following the suggestion in Schmitt-Willich of using the antibody-polymer-gadolinium complex to visualize breast cancer tumors, would have considered it obvious to wash away unbound detecting agent before performing the detecting step. As argued by the examiner, “the presence of such non-specifically bound reagents will preclude or obscure detection of the location of the specifically-bound reagent. If the diagnostic procedure is an endoscopic procedure, which is performed in vivo, the[n] necessarily the step of washing must be performed in vivo.” Answer, page 19. Canto supports the examiner’s position. Canto identifies the location of a specific undesirable esophageal cell type in patients by applying a dye which binds specifically to those cells, and then washing away the excess dye. Canto, page 2. By washing away the non-specifically bound excess dye, Canto was able to determine the location of the undesirable cells. Id. (“Positive staining was defined as blue-stained endoscopically normal esophageal mucosa that persisted despite vigorous water irrigation.”) (Emphasis added.) Thus, in our view, one skilled in the art would have recognized that removing non-specifically bound detecting agent by washing the breast duct would have made itPage: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 NextLast modified: November 3, 2007